ADMA Biologics, Inc.
US ˙ NasdaqGM ˙ US0008991046

SecurityADMA / ADMA Biologics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership649,100 shares
Latest Disclosed Value $ 11,839,584
Barclays Plc ownership in ADMA / ADMA Biologics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 649,100 shares of ADMA Biologics, Inc. (US:ADMA) valued at $11,839,584 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 763,946 shares of ADMA Biologics, Inc.. This represents a change in shares of -15.03% during the quarter. The current value of the position is $5,037,016 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (ADMA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ADMA / ADMA Biologics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ADMA BIOLOGICS COM 000899104 649,100 -114,846 -15.03 11,840 5.71 0.0028
2026-03-31 2025-09-30 13F/A-3 ADMA BIOLOGICS COM 000899104 763,946 -34,774 -4.35 11,199 -23.00 0.0024
2026-03-19 2025-09-30 13F/A-2 ADMA BIOLOGICS COM 000899104 528,629 -270,091 10,567 0.0028
2025-11-12 2025-09-30 13F ADMA BIOLOGICS COM 000899104 763,946 -34,774 11,199 0.0024
2026-02-27 2025-06-30 13F/A-2 ADMA BIOLOGICS COM 000899104 798,720 352,837 79.13 14,545 64.41 0.0033
2025-08-14 2025-06-30 13F/A-1 ADMA BIOLOGICS COM 000899104 798,720 352,837 15 0.0033
2025-08-13 2025-06-30 13F ADMA BIOLOGICS COM 000899104 798,720 352,837 15 0.0011
2026-03-17 2025-03-31 13F/A-1 ADMA BIOLOGICS COM 000899104 445,883 -95,210 -17.60 8,846 -4.67 0.0025
2025-05-15 2025-03-31 13F ADMA BIOLOGICS COM 000899104 445,883 -95,210 9 0.0025
2026-03-19 2024-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 541,093 12,464 2.36 9,280 -12.19 0.0026
2025-02-13 2024-12-31 13F ADMA BIOLOGICS COM 000899104 541,093 12,464 9 0.0026
2026-03-31 2024-09-30 13F/A-2 ADMA BIOLOGICS COM 000899104 528,629 347,692 192.16 10,567 422.60 0.0028
2024-11-19 2024-09-30 13F/A-1 ADMA BIOLOGICS COM 000899104 528,629 347,692 11 0.0028
2024-11-15 2024-09-30 13F ADMA BIOLOGICS COM 000899104 528,629 347,692 11 0.0028
2026-03-23 2024-06-30 13F/A-1 ADMA BIOLOGICS COM 000899104 180,937 -93,112 -33.98 2,023 11.84 0.0006
2024-08-14 2024-06-30 13F ADMA BIOLOGICS COM 000899104 180,937 -93,112 2 0.0006
2026-03-24 2024-03-31 13F/A-1 ADMA BIOLOGICS COM 000899104 274,049 -306,689 -52.81 1,809 -31.10 0.0006
2024-05-15 2024-03-31 13F ADMA BIOLOGICS COM 000899104 274,049 -306,689 2 0.0006
2026-03-25 2023-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 580,738 178,201 44.27 2,625 82.10 0.0010
2024-02-15 2023-12-31 13F ADMA BIOLOGICS COM 000899104 580,738 178,201 3 0.0010
2026-03-26 2023-09-30 13F/A-1 ADMA BIOLOGICS COM 000899104 402,537 -10,544 -2.55 1,441 -5.45 0.0009
2023-11-07 2023-09-30 13F ADMA BIOLOGICS COM 000899104 402,537 -10,544 1 0.0009
2026-03-30 2023-06-30 13F/A-2 ADMA BIOLOGICS COM 000899104 413,081 -15,968 -3.72 1,524 7.32 0.0010
2023-09-20 2023-06-30 13F/A-1 ADMA BIOLOGICS COM 000899104 413,081 -15,968 2 0.0010
2023-08-03 2023-06-30 13F ADMA BIOLOGICS COM 000899104 413,081 -15,968 2 0.0010
2026-03-30 2023-03-31 13F/A-1 ADMA BIOLOGICS COM 000899104 429,049 -35,718 -7.69 1,420 -21.24 0.0007
2023-05-04 2023-03-31 13F ADMA BIOLOGICS COM 000899104 429,049 -35,718 1 0.0007
2026-03-30 2022-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 464,767 -3,949 -0.84 1,803 58.30 0.0008
2023-02-13 2022-12-31 13F ADMA BIOLOGICS COM 000899104 464,767 -3,949 2 0.0008
2022-11-03 2022-09-30 13F ADMA BIOLOGICS COM 000899104 468,716 356,293 316.92 1,139 413.06 0.0012
2022-08-12 2022-06-30 13F ADMA BIOLOGICS COM 000899104 112,423 -4,815 -4.11 222 3.26 0.0001
2022-05-16 2022-03-31 13F ADMA BIOLOGICS COM 000899104 117,238 0 0.00 215 30.30 0.0002
2022-02-23 2021-12-31 13F/A-1 ADMA BIOLOGICS COM 000899104 117,238 -11,714 -9.08 165 13.79 0.0001
2022-02-14 2021-12-31 13F ADMA BIOLOGICS COM 000899104 117,238 -11,714 165 0.0000
2021-11-09 2021-09-30 13F ADMA BIOLOGICS COM 000899104 128,952 -328,795 -71.83 145 -80.22 0.0001
2021-08-13 2021-06-30 13F ADMA BIOLOGICS COM 000899104 457,747 285,322 165.48 733 141.91 0.0003
2021-05-13 2021-03-31 13F ADMA BIOLOGICS COM 000899104 172,425 172,339 200,394.19 303 -58.66 0.0002
2021-02-11 2020-12-31 13F ADMA BIOLOGICS COM 000899104 86 -27,750 -99.69 0 -100.00
2020-11-12 2020-09-30 13F ADMA BIOLOGICS COM 000899104 27,836 -8,191 -22.74 66 -37.74 0.0000
2020-08-12 2020-06-30 13F ADMA BIOLOGICS COM 000899104 36,027 12,727 54.62 106 58.21 0.0001
2020-05-13 2020-03-31 13F ADMA BIOLOGICS COM 000899104 23,300 -51,400 -68.81 67 -77.52 0.0001
2020-02-10 2019-12-31 13F ADMA BIOLOGICS COM 000899104 74,700 -353,887 -82.57 298 -84.37 0.0002
2019-11-15 2019-09-30 13F/A-1 ADMA BIOLOGICS COM 000899104 428,587 410,962 2,331.70 1,907 2,704.41 0.0012
2019-11-14 2019-09-30 13F ADMA BIOLOGICS COM 000899104 428,587 410,962 1,907 440.9006
2019-08-14 2019-06-30 13F ADMA BIOLOGICS COM 000899104 17,625 -37,842 -68.22 68 -67.77 0.0000
2019-05-15 2019-03-31 13F ADMA BIOLOGICS COM 000899104 55,467 55,246 24,998.19 211 21,000.00 0.0001
2019-02-14 2018-12-31 13F ADMA BIOLOGICS COM 000899104 221 -7,031 -96.95 1 -97.78 0.0000
2018-11-14 2018-09-30 13F ADMA BIOLOGICS COM 000899104 7,252 5,864 422.48 45 650.00 0.0000
2018-08-14 2018-06-30 13F ADMA BIOLOGICS COM 000899104 1,388 -1,513 -52.15 6 -53.85 0.0000
2018-05-15 2018-03-31 13F ADMA BIOLOGICS COM 000899104 2,901 2,901 13 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2019-08-14 2019-06-30 13F ADMA BIOLOGICS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F ADMA BIOLOGICS OPT Call 22,500 85 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.